Clinical trial
Feasibility Clinical Trial to Assess the Safety and Potential Effectiveness of Microlyte® DualGuard Wound Dressing on Surgically Created Partial-thickness Donor Site Wounds on Patients Requiring Split- Thickness Skin Grafting; the SAGGA Trial
NCT07695688 is registered in ClinicalTrials.gov with Imbed Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Clinical Trial to Assess the Safety and Potential Effectiveness of Microlyte® DualGuard Wound Dressing on Surgically Created Partial-thickness Donor Site Wounds on Patients Requiring Split- Thickness Skin Grafting; the SAGGA Trial
- Lead sponsor
- Imbed Biosciences
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 30, 2026
- Completion date
- August 31, 2027
- Enrollment
- 53 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
wound care, wound closure